ALMA Ventures is an Israel-linked early-stage investment and company-building platform focused on mental health, brain health, resilience and longevity. It backs science-based technologies spanning digital biomarkers and cognitive screening, care triage and outcome measurement, digital and hybrid therapeutics, neuromodulation and brain–computer interfaces, and platforms supporting treatment-resistant care. Alongside capital, its published approach supports clinical pilots, validation, regulation, reimbursement and expansion into the US. The platform is distinct from the independently governed and funded ALMA Foundation, which supports research, implementation and shared clinical evidence. Its own profile reports founding in 2026; a precise fund launch date, committed corpus and named investments are not publicly established in the reviewed primary sources.
